Saturday, February 18, 2017 7:04:08 PM
Over the past couple of years the FDA has withheld approval of many products as a hammer to force companies to bring their plants up to snuff.
They will only withhold products that are to be made in that deficient plant.
In essence the FDA's position is you can't handle what you have so why should we give you more.
You can read up on the major drug the FDA is holding back from Sanofi/Regeneron because of Sanofi's manufacturing plant.
http://www.fiercepharma.com/manufacturing/sanofi-s-and-regeneron-s-expected-blockbuster-runs-into-fda-manufacturing-concerns
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM